Regulatory T cells in stem cell transplantation: strategies and first clinical experiences

被引：128

作者：

Edinger, Matthias ^{[1
]}

Hoffmann, Petra ^{[1
]}

机构：

[1] Univ Hosp Regensburg, Dept Hematol & Oncol, D-93053 Regensburg, Germany

来源：

CURRENT OPINION IN IMMUNOLOGY | 2011年 / 23卷 / 05期

关键词：

VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; BONE-MARROW-TRANSPLANTATION; IN-VITRO EXPANSION; DNA METHYLATION; LYMPHOPROLIFERATIVE DISORDER; EPIGENETIC CONTROL; CUTTING EDGE; EXPRESSION; RAPAMYCIN;

D O I：

10.1016/j.coi.2011.06.006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The adoptive transfer of donor-type CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) protects from graft-versus-host disease in murine bone marrow transplantation models. Results from first clinical trials exploring such strategies have recently been presented and seem to confirm the efficacy of Treg for the prevention of this severe complication after allogeneic stem cell transplantation. Further improvements in Treg isolation and in vitro expansion technologies will facilitate the broader exploration of Treg therapies, for example, for the treatment of ongoing graft-versus-host disease or the prevention of graft rejection after solid organ transplantation.

引用

页码：679 / 684

页数：6

共 53 条

[1] DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells [J].

Baron, Udo ;

Floess, Stefan ;

Wieczorek, Georg ;

Baumann, Katrin ;

Gruetzkau, Andreas ;

Dong, Jun ;

Thiel, Andreas ;

Boeld, Tina J. ;

Hoffmann, Petra ;

Edinger, Matthias ;

Tuerbachova, Ivana ;

Hamann, Alf ;

Olek, Sven ;

Huehn, Jochen .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (09) :2378-2389

[2] Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin [J].

Basu, Samik ;

Golovina, Tatiana ;

Mikheeva, Tatiana ;

June, Carl H. ;

Riley, James L. .

JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5794-5798

[3] Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells [J].

Battaglia, M ;

Stabilini, A ;

Roncarolo, MG .

BLOOD, 2005, 105 (12) :4743-4748

[4] Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse [J].

Brunkow, ME ;

Jeffery, EW ;

Hjerrild, KA ;

Paeper, B ;

Clark, LB ;

Yasayko, SA ;

Wilkinson, JE ;

Galas, D ;

Ziegler, SF ;

Ramsdell, F .

NATURE GENETICS, 2001, 27 (01) :68-73

[5] Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics [J].

Brunstein, Claudio G. ;

Miller, Jeffrey S. ;

Cao, Qing ;

McKenna, David H. ;

Hippen, Keli L. ;

Curtsinger, Julie ;

DeFor, Todd ;

Levine, Bruce L. ;

June, Carl H. ;

Rubinstein, Pablo ;

McGlave, Philip B. ;

Blazar, Bruce R. ;

Wagner, John E. .

BLOOD, 2011, 117 (03) :1061-1070

[6] CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].

Cohen, JL ;

Trenado, A ;

Vasey, D ;

Klatzmann, D ;

Salomon, BL .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406

[7] IL-1β and IL-2 convert human Treg into TH17 cells [J].

Deknuydt, Florence ;

Bioley, Gilles ;

Valmori, Danila ;

Ayyoub, Maha .

CLINICAL IMMUNOLOGY, 2009, 131 (02) :298-307

[8] The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment [J].

Delgoffe, Greg M. ;

Kole, Thomas P. ;

Zheng, Yan ;

Zarek, Paul E. ;

Matthews, Krystal L. ;

Xiao, Bo ;

Worley, Paul F. ;

Kozma, Sara C. ;

Powell, Jonathan D. .

IMMUNITY, 2009, 30 (06) :832-844

[9]

Di Ianni M, 2011, BLOOD, V117, P3921, DOI DOI 10.1182/BL00D-2010-10-311894

[10] CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].

Edinger, M ;

Hoffmann, P ;

Ermann, J ;

Drago, K ;

Fathman, CG ;

Strober, S ;

Negrin, RS .

NATURE MEDICINE, 2003, 9 (09) :1144-1150

← 1 2 3 4 5 6 →